BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $40,970,000 | -2.6% | 39,535,000 | 0.0% | 0.04% | -9.8% |
| Q2 2018 | $42,082,000 | +3.5% | 39,535,000 | 0.0% | 0.04% | +5.1% |
| Q1 2018 | $40,671,000 | -9.6% | 39,535,000 | -3.8% | 0.04% | +8.3% |
| Q4 2017 | $45,006,000 | -1.9% | 41,080,000 | 0.0% | 0.04% | -10.0% |
| Q3 2017 | $45,881,000 | -0.5% | 41,080,000 | 0.0% | 0.04% | -11.1% |
| Q2 2017 | $46,115,000 | -1.1% | 41,080,000 | 0.0% | 0.04% | -2.2% |
| Q1 2017 | $46,624,000 | -1.3% | 41,080,000 | 0.0% | 0.05% | +9.5% |
| Q4 2016 | $47,238,000 | -47.7% | 41,080,000 | -45.7% | 0.04% | -52.3% |
| Q3 2016 | $90,241,000 | +44.2% | 75,595,000 | +34.3% | 0.09% | +31.3% |
| Q2 2016 | $62,600,000 | +0.7% | 56,270,000 | +3.7% | 0.07% | -5.6% |
| Q1 2016 | $62,139,000 | +34.3% | 54,270,000 | +50.7% | 0.07% | +36.5% |
| Q4 2015 | $46,286,000 | -14.2% | 36,020,000 | -12.9% | 0.05% | -18.8% |
| Q3 2015 | $53,973,000 | -15.3% | 41,345,000 | 0.0% | 0.06% | -5.9% |
| Q2 2015 | $63,713,000 | – | 41,345,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|